SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-19-257726
Filing Date
2019-09-30
Accepted
2019-09-27 18:51:34
Documents
1
Group Members
LEDO CAPITAL, LLCNEWTYN CAPITAL PARTNERS, LPNEWTYN PARTNERS, LPNOAH G. LEVY

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d810121dsc13da.htm SC 13D/A 100111
  Complete submission text file 0001193125-19-257726.txt   101768
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86778 | Film No.: 191123430
SIC: 2834 Pharmaceutical Preparations

Mailing Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165
Business Address 60 EAST 42ND STREET SUITE 960 NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

IRS No.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13D/A